End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
0.1561 USD | -2.25% |
|
-6.64% | -21.16% |
Business Summary
Number of employees: 12
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Vaccine Discovery and Development
100.0
%
| 0 | nan % | 0 | 100.0 % | - |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Switzerland
100.0
%
| - | - | 0 | 100.0 % | - |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Ralph Schiess
CEO | Chief Executive Officer | 46 | Dec. 14 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Thomas Meier
BRD | Director/Board Member | 62 | Feb. 05 |
Ajit Singh
BRD | Director/Board Member | 60 | Feb. 06 |
James Sapirstein
CHM | Chairman | 63 | - |
Timothy Ramdeen
BRD | Director/Board Member | 32 | 22-12-31 |
Simon Tarsh
BRD | Director/Board Member | 63 | 22-07-31 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 22,848,876 | 20,389,405 ( 89.24 %) | 517,399 ( 2.264 %) | 89.24 % |
Company contact information
![address Onconetix, Inc.(ONCO)](https://cdn.zonebourse.com/static/address/133576962.png)
Sector
Sales per region
1st Jan change | Capi. | |
---|---|---|
-21.16% | 3.49M | |
+4.57% | 97.7B | |
+5.66% | 41.43B | |
-12.80% | 32.85B | |
+80.99% | 29.33B | |
-15.53% | 15.47B | |
-8.70% | 12.89B | |
-12.22% | 11.51B | |
+183.25% | 10.74B | |
-55.41% | 8.97B |
- Stock Market
- Equities
- ONCO Stock
- Company Onconetix, Inc.